May 2, 2016 -- TORONTO--(BUSINESS WIRE)--Synaptive Medical Inc., is pleased to announce the Food and Drug Administration clearance of ImageDrive™ Pro, an informatics platform designed to seamlessly integrate their existing BrightMatter™ technologies. In 2015, Synaptive Medical acquired imaging informatics solutions developer ClearCanvas as a foundation to unify new functionality. The result is interoperability across BrightMatter solutions that span state-of-the-art imaging, surgical planning, navigation, and automated positioning of high definition optics.

“The need for deeper interconnectivity and integration of our own systems and data platforms is essential as we look at introducing novel imaging and sensing technologies in the near future”

The massive challenge in achieving the goal of precision medicine is a standardized approach to capturing data on a health informatics platform that performs analytics at a large scale, while ensuring patient privacy. “The need for deeper interconnectivity and integration of our own systems and data platforms is essential as we look at introducing novel imaging and sensing technologies in the near future,” said Cameron Piron, President of Synaptive Medical. “Our platform is uniquely designed to provide transformative data insights and make an impact in the continuum of care for patients undergoing various surgical treatments,” he said.
Synaptive Medical’s Informatics Platform will immediately enable a more patient-centric and unified experience for interdisciplinary review. “Efficient care collaboration across multiple clinical specialties to offer patients the best available treatment can be met with barriers to having all the critical information,” said Wes Hodges, Director of Informatics & External Collaboration. “We see the opportunity to immediately start solving some of the inefficiencies today,” he said. In addition to data capture and analytics, a quality assurance module ensures the scan meets the minimum requirements for surgical planning and visualization of a patient’s unique fiber tracts.

The rapid growth and adoption of Synaptive Medical’s technology has opened a new level of discussion with its diverse set of clinical and research users. There is a tremendous amount of interest in optimizing the secure flow of imaging and non-imaging data. With initiatives like The Human Genome Project, Cancer Moonshot, and the recent White House’s announcement to accelerate precision medicine, secure data exchange between clinical and research environments will need to be scalable, automated and ensure patient confidentiality. Researchers will benefit from automated data distribution, de-identification, and extensibility using well-established protocols. Data is easily de-identified and can be and shared with collaborators using well-established secure mechanisms.

Products and Clearances Homepage